GoodRx Holdings (GDRX) Operating Margin (2019 - 2026)
GoodRx Holdings (GDRX) reported Operating Margin of 7.22% for Q1 2026, down 430.0% on a YoY basis from 2.19% in Q1 2025, and down 37.99% sequentially from 11.65% in Q4 2025.
GoodRx Holdings (GDRX) Operating Margin (2019 - 2026) Analysis & Trends
GoodRx Holdings (GDRX) has 8 years of Operating Margin data on file, last reported at 7.22% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 430.0% year-over-year to 7.22%; the trailing twelve-month figure through Mar 2026 stood at 9.92% (down 35.0% YoY), and the FY2025 full-year result was 10.98%, up 267.0% from the prior year.
- Operating Margin eased to 7.22% in Q1 2026, from 11.65% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 13.2% in Q2 2025 to a low of 21.3% in Q3 2023.
- A 5-year average of 4.1% and a median of 7.46% in 2025 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin tumbled 1291 bps in 2023 and jumped 3175 bps in 2024, its largest moves.
- Tracing GDRX's Operating Margin over 5 years: stood at 0.94% in 2022, then slumped by 1086 bps to 9.3% in 2023, then surged by 198 bps to 9.15% in 2024, then increased by 27 bps to 11.65% in 2025, then sank by 38 bps to 7.22% in 2026.
- Business Quant data shows GDRX's Operating Margin at 7.22% in Q1 2026, 11.65% in Q4 2025, and 7.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 33.04 Bn | 25.73 Bn | 662.02 Mn | 30.93% |
| 2 | Healthequity | 8.57 Bn | 8.30 Bn | 256.31 Mn | 29.03% |
| 3 | 10x Genomics | 5.94 Bn | 5.40 Bn | 106.18 Mn | -11.30% |
| 4 | Hinge Health | 5.91 Bn | 5.59 Bn | 154.23 Mn | 17.59% |
| 5 | MiniMed | 4.63 Bn | 4.33 Bn | 480.00 Mn | -11.11% |
| 6 | Waystar Holding | 4.61 Bn | 4.55 Bn | 216.84 Mn | 25.64% |
| 7 | Doximity | 4.02 Bn | 3.27 Bn | 125.97 Mn | 17.08% |
| 8 | Privia Health | 3.09 Bn | 2.67 Bn | - | 1.23% |
| 9 | Omnicell | 1.94 Bn | 1.70 Bn | 140.36 Mn | 5.44% |
| 10 | GoodRx Holdings | 1.05 Bn | 813.13 Mn | 173.85 Mn | 7.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.22% |
| Dec 31, 2025 | 11.65% |
| Sep 30, 2025 | 7.46% |
| Jun 30, 2025 | 13.20% |
| Mar 31, 2025 | 11.52% |
| Dec 31, 2024 | 9.15% |
| Sep 30, 2024 | 10.45% |
| Jun 30, 2024 | 9.91% |
| Mar 31, 2024 | 3.73% |
| Dec 31, 2023 | -9.30% |
| Sep 30, 2023 | -21.30% |
| Jun 30, 2023 | 9.65% |
| Mar 31, 2023 | 6.14% |
| Dec 31, 2022 | 0.94% |
| Sep 30, 2022 | -8.39% |
| Jun 30, 2022 | -2.11% |
| Mar 31, 2022 | 9.72% |
| Dec 31, 2021 | 5.51% |
| Sep 30, 2021 | 3.59% |
| Jun 30, 2021 | -0.20% |